Business Description
BriaCell Therapeutics Corp. is a Canadian cancer treatment company focused on creating new ways to help the immune system fight tumors. Its most advanced treatment, Bria-IMT, is currently being tested in a Phase 3 trial for patients with late-stage breast cancer, while other programs are being developed to target a broader range of cancer types. The company works with leading research institutions, including a partnership with MSK Accelerator and a licensing agreement with the University of Maryland Baltimore County, to advance its pipeline of immune-based therapies.
